Clinical trial
An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life
NCT07719088 is registered in ClinicalTrials.gov with Charles Raison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life
- Lead sponsor
- Charles Raison
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- December 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, biomarkers of aging, longevity